CureVac NV (5CV) — Strategic Asset Allocation Index
CureVac NV (5CV) has a Strategic Asset Allocation Index of 45.2% as of September 2023. Strategic assets (PP&E of €272.22 Million plus long-term investments of €-) total €272.22 Million, measured against net assets of €602.26 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
CureVac NV Strategic Asset Allocation Index (2018–2021)
This chart shows how CureVac NV's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2021. As of September 2023, the index stands at 45.2%, representing strategic assets of €272.22 Million against net assets of €602.26 Million EUR. Explore 5CV operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for CureVac NV (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for CureVac NV from 2018 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CureVac NV market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 29.1% | €200.39 Million | €200.39 Million | €- | €688.48 Million | ▲ +15.0 pp |
| 2020 | 14.1% | €100.59 Million | €100.59 Million | €- | €711.35 Million | ▼ -112.0 pp |
| 2018 | 126.1% | €40.47 Million | €40.47 Million | €- | €32.08 Million | — |